Myriad Genetics Inc

Small-Cap Stocks Penny Stocks Biotech Stocks Healthcare Stocks

$4.27

+0.18 (+4.40%)

As of May 9, 1:48 AM ET ·

Analyst Consensus

Sell

Analysts

High

Coverage

Buy 3 17%

Hold 9 50%

Sell 6 33%

Price Target

Analyst Price Target +870.5% upside

Low Target $29.39

Average Target $41.44

High Target $63.29

Current Price $4.27

Current
$4.27

Target
$41.44

$29.39 $41.44 avg $63.29

Scenario Analysis

Bear Case

$29.39

588.3%

Low target

Base Case

$41.44

+870.5%

Avg target

Bull Case

$63.29

+1,382.2%

High target

Risk/Reward

2.3x

Favorable

Price in Context

52-Week High

$8.59

-50.3% from high

52-Week Low

$3.75

+13.9% from low

Target vs 52W High

$41.44

+382.4% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	75%	$257.58	+27.8%
AMGN Amgen Inc	Hold	44	48%	$190.87	-42.5%
GILD Gilead Sciences Inc	Strong Buy	39	79%	$362.68	+176.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	79%	$438.34	+2.0%
REGN Regeneron Pharmaceuticals	Strong Buy	38	79%	$76.80	-89.3%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-65.3%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-19.5%
INSM Insmed Inc	Strong Buy	28	96%	$143.40	+41.5%